Literature DB >> 1459817

Prognostic variables in patients with prostate cancer: influence of blood group ABO (H), the Rhesus system, age, differentiation, tumour stage and metastases.

E Kvist1, J Krogh, P Hjortberg.   

Abstract

Among 279 patients with carcinoma of the prostate no relationship was observed in survival between blood groups ABO (H) or the rhesus system. Age at diagnosis is relevant for the outcome of the disease, but grade of differentiation, tumour stage and metastases are more important predictors of survival.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1459817     DOI： 10.1007/bf02550636

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


  15 in total

1.  The prognosis in carcinoma of the prostate, judged on the basis of clinical classification into stages and histological grading.

Authors:  H M Nissen; F R Mathiesen; V Grau
Journal:  Int Urol Nephrol       Date:  1977       Impact factor: 2.370

2.  Relationship between blood groups and bladder tumors.

Authors:  E Kvist; P Raabye; K Andreassen
Journal:  Scand J Urol Nephrol       Date:  1989

Review 3.  Manifestations of advanced prostate cancer: prognosis and treatment.

Authors:  B V Surya; J A Provet
Journal:  J Urol       Date:  1989-10       Impact factor: 7.450

4.  Survival of patients with incidentally found microscopic cancer of the prostate: results of a clinical trial of conservative treatment.

Authors:  D P Byar
Journal:  J Urol       Date:  1972-12       Impact factor: 7.450

5.  Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Examined by the step-section technique.

Authors:  D P Byar; F K Mostofi
Journal:  Cancer       Date:  1972-07       Impact factor: 6.860

6.  Deferred treatment for prostate cancer.

Authors:  R Handley; T W Carr; D Travis; P H Powell; R R Hall
Journal:  Br J Urol       Date:  1988-09

7.  Nuclear DNA analysis of prostate tissues: correlation with stage and grade of tumour.

Authors:  W A Neill; M Norval; F K Habib
Journal:  Urol Int       Date:  1989       Impact factor: 2.089

8.  Age, and size and grade of tumour predict prognosis in incidentally diagnosed carcinoma of the prostate.

Authors:  C M Goodman; A Busuttil; G D Chisholm
Journal:  Br J Urol       Date:  1988-12

9.  Prostate cancer in men less than 45 years old: influence of stage, grade and therapy.

Authors:  M C Benson; S A Kaplan; C A Olsson
Journal:  J Urol       Date:  1987-05       Impact factor: 7.450

10.  Bone marrow prostatic specific antigen and prostatic acid phosphatase levels: are they helpful in staging prostatic cancer?

Authors:  J Morote; A Ruibal; C Pascual; J Palou; J A de Torres
Journal:  J Urol       Date:  1987-05       Impact factor: 7.450
View more
  7 in total

1.  Associations between ABO blood groups and biochemical recurrence after radical prostatectomy.

Authors:  Yoshio Ohno; Makoto Ohori; Jun Nakashima; Hidenori Okubo; Naoya Satake; Issei Takizawa; Takeshi Hashimoto; Riu Hamada; Yoshihiro Nakagami; Kunihiko Yoshioka; Masaaki Tachibana
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  ABO blood group polymorphism has an impact on prostate, kidney and bladder cancer in association with longevity.

Authors:  Donatas Stakišaitis; Milda Juknevičienė; Albertas Ulys; Dalia Žaliūnienė; Daiva Stanislovaitienė; Ramunė Šepetienė; Anželika Slavinska; Kęstutis Sužiedėlis; Vita Lesauskaitė
Journal:  Oncol Lett       Date:  2018-05-21       Impact factor: 2.967

3.  ABO blood types and cancer risk--a cohort study of 339,432 subjects in Taiwan.

Authors:  Wenjie Sun; Chi-Pang Wen; Jie Lin; Christopher Wen; Xia Pu; Maosheng Huang; Min Kuang Tsai; Chwen Keng Tsao; Xifeng Wu; Wong-Ho Chow
Journal:  Cancer Epidemiol       Date:  2015-01-16       Impact factor: 2.984

4.  The Rhesus D-negative phenotype is an independent predictor of poor prognosis in curatively (RO) resected gastric cancer patients.

Authors:  B Mayer; W Schraut; I Funke; K W Jauch; W Mempel; J P Johnson; F W Schildberg
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 5.  The role of the histoblood ABO group in cancer.

Authors:  Seth K Rummel; Rachel E Ellsworth
Journal:  Future Sci OA       Date:  2016-03-15

6.  AB0/Rhesus Blood Group Does Not Influence Clinicopathological Tumor Characteristics or Oncological Outcome in Patients Undergoing Radical Prostatectomy.

Authors:  Su Jung Oh; Philipp Mandel; Felix K H Chun; Pierre Tennstedt; Sven Peine; Jan Lukas Hohenhorst; Jens Hiller; Markus Graefen; Derya Tilki; Thomas Steuber
Journal:  Front Surg       Date:  2017-12-18

7.  ABO blood type correlates with survival on prostate cancer vaccine therapy.

Authors:  Saddam M Muthana; James L Gulley; James W Hodge; Jeffrey Schlom; Jeffrey C Gildersleeve
Journal:  Oncotarget       Date:  2015-10-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.